Breyanzi यूरोपीय संघ - स्लोवाक - EMA (European Medicines Agency)

breyanzi

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastické činidlá - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.

Náplasť Cura-Heat®Back Pain MAX Size Direct to Skin स्लोवाकिया - स्लोवाक - ŠÚKL (Štátny ústav pre kontrolu liečiv)

náplasť cura-heat®back pain max size direct to skin

kobayashi healthcare europe ltd gunnersbury avenue 272 w4 5qb london, chiswick spojené kráľovstvo veľkej británie a severného Írska -